C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/44 (2006.01) A61K 31/444 (2006.01) A61P 29/00 (2006.01) C07D 213/61 (2006.01) C07D 213/65 (2006.01) C07D 213/75 (2006.01) C07D 213/89 (2006.01)
Patent
CA 2412968
The invention encompasses the novel compound of formula (I) (see Formula I) as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of formula (I).
L'invention porte sur le nouveau composé ayant la formule (I) (voir la formule I), de même qu'une méthode permettant de traiter les maladies mettant en cause la COX-2. La méthode comprend l'administration d'une quantité thérapeutiquement efficace et non toxique du composés de formule I à un patient nécessitant ce traitement. L'invention porte aussi sur certaines compositions pharmaceutiques permettant de traiter des maladies faisant intervenir la COX-2, contenant des composés de la formule I.
Dube Daniel
Fortin Rejean
Friesen Richard
Gauthier Jacques Yves
Wang Zhaoyin
Merck Frosst Canada & Co.
Merck Frosst Canada Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Substituted pyridines as selective cyclooxygenase-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyridines as selective cyclooxygenase-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyridines as selective cyclooxygenase-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1927613